IFP Advisors’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
IFP Advisors's ORKA Position: Q3 2026 in Review
IFP Advisors held its Oruka Therapeutics (ORKA) position steady in Q3 2026 at 10 shares worth $833. The position accounts for ﹤0.01% of the portfolio, ranked #4540.
IFP Advisors first reported a position in ORKA in Q3 2025 and has held it in 5 quarters since. The position peaked at $952 in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- IFP Advisors held 10 shares of Oruka Therapeutics worth $833 as of Q3 2026.
- IFP Advisors left its Oruka Therapeutics share count unchanged in Q3 2026.
- Oruka Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4540 holding.
- IFP Advisors first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 5 quarters since.
- IFP Advisors's Oruka Therapeutics position peaked at $952 in Q2 2026.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.